Article: Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy.
bioRxiv : the preprint server for biology
2024
Abstract: A central problem in cancer immunotherapy with immune checkpoint blockade (ICB) is the development of resistance, which affects 50% of patients with metastatic ... ...
Abstract | A central problem in cancer immunotherapy with immune checkpoint blockade (ICB) is the development of resistance, which affects 50% of patients with metastatic melanoma |
---|---|
Language | English |
Publishing date | 2024-03-26 |
Publishing country | United States |
Document type | Preprint |
DOI | 10.1101/2024.02.12.579184 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.